Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline-Reference-Cited by-同舟云学术

Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline

Published:2019-12-17 Issue:1 Volume:26 Page:6-16
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Gray Elaine¹^ORCID,Kitchen Steve²^ORCID,Bowyer Annette²^ORCID,Chowdary Pratima³^ORCID,Jenkins P. Vincent⁴^ORCID,Murphy Paul⁵,Platton Sean⁶,Riddell Anne³,Lester Will⁷^ORCID

Affiliation:

1. Haemostasis Section, Biotherapeutics Group National Institute for Biological Standards and Control Potters Bar UK

2. Department of Coagulation Royal Hallamshire Hospital Sheffield UK

3. Katharine Dormandy Haemophilia and Thrombosis Centre Royal Free Hospital London UK

4. Haematology Department Haemostasis Laboratory University Hospital of Wales Cardiff UK

5. Haemostasis Department Newcastle Upon Tyne Hospitals Newcastle upon Tyne UK

6. The Royal London Hospital Haemophilia Centre The Royal London Hospital London UK

7. Haemophilia Unit University Hospitals Birmingham Birmingham UK

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13907

Reference61 articles.

1. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A

2. Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A

3. Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B

4. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

5. AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Factor VIII Concentrates Using Clot Waveform Analysis;Journal of Clinical Medicine;2024-06-30

2. Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec;Thrombosis and Haemostasis;2024-06-11

3. Evaluation of one‐stage and chromogenic assays for the laboratory measurement of factor VIII activity following valoctocogene roxaparvovec infusion;Haemophilia;2024-06-06

4. Modern aspects of hemophilia A diagnosis;Pediatric Hematology/Oncology and Immunopathology;2024-04-18

5. Variability in combinations of APTT reagent and substrate plasma for a one‐stage clotting assay to measure factor VIII products;International Journal of Laboratory Hematology;2024-03